1. Home
  2. FOR vs BHVN Comparison

FOR vs BHVN Comparison

Compare FOR & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$24.98

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$9.51

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
BHVN
Founded
2005
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2007
2022

Fundamental Metrics

Financial Performance
Metric
FOR
BHVN
Price
$24.98
$9.51
Analyst Decision
Strong Buy
Buy
Analyst Count
4
14
Target Price
$31.75
$28.85
AVG Volume (30 Days)
108.9K
2.1M
Earning Date
04-21-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
0.30
N/A
Revenue
$1,662,400,000.00
N/A
Revenue This Year
$0.52
N/A
Revenue Next Year
$7.72
N/A
P/E Ratio
$81.50
N/A
Revenue Growth
10.14
N/A
52 Week Low
$18.00
$7.48
52 Week High
$30.74
$24.06

Technical Indicators

Market Signals
Indicator
FOR
BHVN
Relative Strength Index (RSI) 41.62 48.62
Support Level $24.20 $9.41
Resistance Level $26.06 $10.28
Average True Range (ATR) 0.79 0.59
MACD 0.01 0.04
Stochastic Oscillator 38.60 61.54

Price Performance

Historical Comparison
FOR
BHVN

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: